These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 25108776

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Grade Gliomas in Children and Adolescents.
    Lee JW, Lim DH, Sung KW, Lee HJ, Yi ES, Yoo KH, Koo HH, Suh YL, Shin HJ.
    J Korean Med Sci; 2017 Feb; 32(2):195-203. PubMed ID: 28049229
    [Abstract] [Full Text] [Related]

  • 3. Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study.
    Lee JW, Lee S, Cho HW, Ma Y, Yoo KH, Sung KW, Koo HH, Cho EJ, Lee SK, Lim DH.
    J Hematol Oncol; 2017 May 16; 10(1):108. PubMed ID: 28511709
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
    Sung KW, Son MH, Lee SH, Yoo KH, Koo HH, Kim JY, Cho EJ, Lee SK, Choi YS, Lim DH, Kim JS, Kim DW.
    Bone Marrow Transplant; 2013 Jan 16; 48(1):68-73. PubMed ID: 22635247
    [Abstract] [Full Text] [Related]

  • 7. Tandem high-dose chemotherapy with autologous stem cell rescue for stage M high-risk neuroblastoma: Experience using melphalan/etoposide/carboplatin and busulfan/melphalan regimens.
    Kato S, Kubota Y, Watanabe K, Hogetsu K, Arakawa Y, Koh K, Takita J, Hiwatari M.
    Pediatr Transplant; 2020 Nov 16; 24(7):e13772. PubMed ID: 32543778
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multimodal treatment including tandem high-dose chemotherapy and autologous stem cell transplantation in children with anaplastic ependymomas.
    Lee JW, Lim DH, Sung KW, Lee HJ, Yi ES, Yoo KH, Koo HH, Suh YL, Shin HJ.
    Pediatr Transplant; 2018 May 16; 22(3):e13127. PubMed ID: 29453811
    [Abstract] [Full Text] [Related]

  • 11. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system.
    Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC, Lim DH, Kim HS.
    J Korean Med Sci; 2012 Feb 16; 27(2):135-40. PubMed ID: 22323859
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of regimen-related toxicity between high-dose melphalan and ICE as a preparatory regimen for autologous stem cell transplantation].
    Imataki O, Aoyama T, Tamai Y, Kawakami K.
    Gan To Kagaku Ryoho; 2007 Oct 16; 34(10):1633-6. PubMed ID: 17940379
    [Abstract] [Full Text] [Related]

  • 13. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U.
    Klin Padiatr; 1998 Oct 16; 210(4):248-55. PubMed ID: 9743961
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Atypical Teratoid/Rhabdoid Tumor.
    Sung KW, Lim DH, Yi ES, Choi YB, Lee JW, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ.
    Cancer Res Treat; 2016 Oct 16; 48(4):1408-1419. PubMed ID: 27034140
    [Abstract] [Full Text] [Related]

  • 16. Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.
    Lee JL, Gooley T, Bensinger W, Schiffman K, McDonald GB.
    Biol Blood Marrow Transplant; 1999 Oct 16; 5(5):306-15. PubMed ID: 10534061
    [Abstract] [Full Text] [Related]

  • 17. Tandem high-dose chemotherapy and auto-SCT for malignant brain tumors in children under 3 years of age.
    Sung KW, Lim DH, Lee SH, Yoo KH, Koo HH, Kim JH, Suh YL, Joung YS, Shin HJ.
    Bone Marrow Transplant; 2013 Jul 16; 48(7):932-8. PubMed ID: 23318534
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.
    Choi YB, Bae GE, Lee NH, Kim JS, Lee SH, Yoo KH, Sung KW, Koo HH.
    J Korean Med Sci; 2015 Aug 16; 30(8):1062-7. PubMed ID: 26240483
    [Abstract] [Full Text] [Related]

  • 20. Feasibility and effectiveness of treatment strategy of tandem high-dose chemotherapy and autologous stem cell transplantation in combination with 131 I-MIBG therapy for high-risk neuroblastoma.
    Suh JK, Koh KN, Min SY, Kim YS, Kim H, Im HJ, Namgoong JM, Kim DY, Ahn SD, Lee JJ, Seo JJ.
    Pediatr Transplant; 2020 Mar 16; 24(2):e13658. PubMed ID: 31960542
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.